TZIELD ® Phase 3 data presented at ISPAD shows potential to slow the progression of Stage 3 type 1 diabetes in newly diagnosed children and adolescents; full data simultaneously published in The New ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results